Drug Design Amongst the Vines, Hunter Valley, 3-7 December 2006 (PDF 1.4 MB)
6th Australia/Japan Symposium on Drug Design and Development, Sydney 27-30 June 2004 (PDF 1.7 MB)
The Laboratory's expertise is in the medicinal chemistry, neurochemistry and neuropharmacology of the amino acid neurotransmitters GABA and glutamate, and of ATP-gated potassium channels. The Laboratory has projects involving the design, synthesis and evaluation of new chemical entities as investigational and as therapeutic agents. The major target disorders include Alzheimer's disease, anxiety disorders, diabetes epilepsy and schizophrenia.
The Adrien Albert Laboratory was to be officially opened by Albert in January 1990, when he was to have been presented with the Royal Australian Chemical Insitute's Ollé Prize in Sydney for his last book 'Xenobiosis: Food, Drugs and Poisons in the Human Body'. Unfortunately, his health suddenly deteriorated and he died in Canberra on 29 December 1989. As he fell ill, he learned also that he had been awarded a DSc (honoris causa) from the University of Sydney. This degree was conferred posthumously in March 1990. Albert's remarkable scientific career, after graduating from the University of Sydney with a BSc (First Class Honours in Chemistry) and the University Medal in 1932, continued right up to his death. His great contributions to medicinal chemistry in Australia have been commemorated by the naming after him of the Adrien Albert Laboratory of Medicinal Chemistry at the University of Sydney and by the Royal Australian Chemical Institute's Division of Medicinal and Agricultural Chemistry (now the RACI Division of Biomolecular Chemistry) naming its most distinguished award, The Adrien Albert Award. The Royal Society of Chemistry in the UK have instituted an Adrien Albert Lectureship, while the Australian National University has established an Adrien Albert Prize for chemistry honours students.
The Adrien Albert Laboratory of Medicinal Chemistry is the centre of an integrated drug design and development unit with particular expertise in:
Opportunities exist in the Laboratory for collaborative industrial R&D projects that offer high intellectual interest for university researchers, together with unique entry-level commercial opportunities for investors and industrial partners leading to patentable new chemical entities.
Please contact either:
Associate Professor Robin Allan
The Adrien Albert Laboratory of Medicinal Chemistry
Department of Pharmacology, D06
The University of Sydney
NSW 2006 Australia
Phone/voice mail (within Australia) 02 9351 3443; Fax (within
Australia) 02 9351 3868
Phone/voice mail (outside Australia) 61 92 351 3443; Fax
(outside Australia) 61 2 9351 3868
E-mail r_allan@pharmacol.usyd.edu.au
or
Professor Graham Johnston
The Adrien Albert Laboratory of Medicinal Chemistry
Department of Pharmacology, D06
The University of Sydney
NSW 2006 Australia
Phone/voice mail (within Australia) 02 9351 6117; Fax (within
Australia) 02 9351 3868
Phone/voice mail (outside Australia) 61 2 9351 6117; Fax
(outside Australia) 61 2 9351 3868
E-mail grahamj@mail.usyd.edu.au
Return to Department of Pharmacology Home Page